These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28934518)

  • 41. An acute hemolytic transfusion reaction caused by dog erythrocyte antigen 1.1 incompatibility in a previously sensitized dog.
    Giger U; Gelens CJ; Callan MB; Oakley DA
    J Am Vet Med Assoc; 1995 May; 206(9):1358-62. PubMed ID: 7775248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute hemolytic transfusion reaction due to a warm reactive anti-A
    Helmich F; Baas I; Ligthart P; Bosch M; Jonkers F; de Haas M; van der Graaf F
    Transfusion; 2018 May; 58(5):1163-1170. PubMed ID: 29484668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.
    Tiwari AK; Aggarwal G; Dara RC; Arora D; Gupta GK; Raina V
    Asian J Transfus Sci; 2017; 11(1):40-44. PubMed ID: 28316439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Compatibility problems in transfusion. Special reference to the delayed hemolytic transfusion reaction].
    Nordhagen R; Wolthuis K
    Tidsskr Nor Laegeforen; 1990 Jun; 110(15):1933-5. PubMed ID: 2363162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of incompatible crossmatch results in dogs admitted to a veterinary teaching hospital with no history of prior red blood cell transfusion.
    Odunayo A; Garraway K; Rohrbach BW; Rainey A; Stokes J
    J Am Vet Med Assoc; 2017 Feb; 250(3):303-308. PubMed ID: 28117642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Practical Solutions for Problems in Blood Grouping and Crossmatching.
    Andıç N
    Turk J Haematol; 2022 Feb; 39(1):55-60. PubMed ID: 34886658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-A antibody transfused with non-group-specific platelets. Serological abnormalities.
    Thomas L; Tuscany FL; Wilner GD
    Arch Pathol Lab Med; 1981 Jan; 105(1):52-3. PubMed ID: 6893913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute hemolytic transfusion reaction due to anti-Le(b).
    Irani MS; Figueroa D; Savage G
    Transfusion; 2015 Oct; 55(10):2486-8. PubMed ID: 26018602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postpartum acute hemolytic transfusion reactions associated with anti-Lea in two pregnancies complicated by preeclampsia.
    Marchese M
    Immunohematology; 2017 Sep; 33(3):114-118. PubMed ID: 29043829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pretransfusion testing without serologic crossmatch: approaches to ensure patient safety.
    Kuriyan M; Fox E
    Vox Sang; 2000; 78(2):113-8. PubMed ID: 10765147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased alloimmunisation and transfusion reaction reporting in patients with solid-phase panreactivity.
    Olofson AM; Chandler RM; Marx-Wood CR; Babcock CA; Dunbar NM
    J Clin Pathol; 2017 Nov; 70(11):981-983. PubMed ID: 28424235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemolytic transfusion reaction attributable to anti-Dia.
    Joyce AJ; Quantock KM; Banh R; Liew YW
    Immunohematology; 2017 Jan; 33(1):6-8. PubMed ID: 28425749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incomplete pretransfusion testing leads to surgical delays.
    McWilliams B; Yazer MH; Cramer J; Triulzi DJ; Waters JH
    Transfusion; 2012 Oct; 52(10):2139-44; quiz 2145. PubMed ID: 22348700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. When should antibody screening tests be done for recently transfused patients?
    Shulman IA; Nelson JM; Nakayama R
    Transfusion; 1990 Jan; 30(1):39-41. PubMed ID: 2296788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and cost-containment data that advocate abbreviated pretransfusion testing.
    Cordle DG; Strauss RG; Snyder EL; Floss AM
    Am J Clin Pathol; 1990 Oct; 94(4):428-31. PubMed ID: 2220670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical consequences of a 30-day interval between antibody identifications.
    Steele J; Herman M; Norfolk A; Haspel RL
    Transfusion; 2023 Jan; 63(1):30-34. PubMed ID: 36433801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delayed hemolytic transfusion reaction due to anti-S antibody in patient with anti-Jk(a) autoantibody and multiple alloantibodies.
    Guastafierro S; Sessa F; Cuomo C; Tirelli A
    Ann Hematol; 2004 May; 83(5):307-8. PubMed ID: 15064858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute hemolytic transfusion reactions due to multiple alloantibodies including anti-E, anti-c and anti-Jkb.
    Park TS; Kim KU; Jeong WJ; Kim HH; Chang CL; Chung JS; Cho GJ; Lee EY; Son HC
    J Korean Med Sci; 2003 Dec; 18(6):894-6. PubMed ID: 14676451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can the interval between antibody identifications be increased for alloimmunized patients?
    Goss C; Avecilla ST; Garbaini J; Degtyaryova D; Lo D; Chang DY; Cushing M
    Transfusion; 2016 Feb; 56(2):334-8. PubMed ID: 26456540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.